|
|
|
|
LEADER |
02645 am a22003973u 4500 |
001 |
125979 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Lu, Lenette L.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biological Engineering
|e contributor
|
700 |
1 |
0 |
|a Smith, Malisa T.
|e author
|
700 |
1 |
0 |
|a Yu, Krystle K. Q.
|e author
|
700 |
1 |
0 |
|a Luedemann, Corinne
|e author
|
700 |
1 |
0 |
|a Suscovich, Todd J.
|e author
|
700 |
1 |
0 |
|a Grace, Patricia S.
|e author
|
700 |
1 |
0 |
|a Cain, Adam
|e author
|
700 |
1 |
0 |
|a Yu, Wen-Han
|e author
|
700 |
1 |
0 |
|a McKitrick, Tanya R.
|e author
|
700 |
1 |
0 |
|a Lauffenburger, Douglas A
|e author
|
700 |
1 |
0 |
|a Cummings, Richard D.
|e author
|
700 |
1 |
0 |
|a Mayanja-Kizza, Harriet
|e author
|
700 |
1 |
0 |
|a Hawn, Thomas R.
|e author
|
700 |
1 |
0 |
|a Boom, W. Henry
|e author
|
700 |
1 |
0 |
|a Stein, Catherine M.
|e author
|
700 |
1 |
0 |
|a Fortune, Sarah M.
|e author
|
700 |
1 |
0 |
|a Seshadri, Chetan
|e author
|
700 |
1 |
0 |
|a Alter, Galit
|e author
|
245 |
0 |
0 |
|a IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
|
260 |
|
|
|b Springer Science and Business Media LLC,
|c 2020-06-25T14:49:00Z.
|
856 |
|
|
|z Get fulltext
|u https://hdl.handle.net/1721.1/125979
|
520 |
|
|
|a Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is identified using the tuberculin skin test and interferon-γ (IFN-γ) release assay IGRA, and a positive result may prompt chemoprophylaxis to prevent progression to tuberculosis. In the present study, we report on a cohort of Ugandan individuals who were household contacts of patients with TB. These individuals were highly exposed to Mtb but tested negative disease by IFN-γ release assay and tuberculin skin test, 'resisting' development of classic LTBI. We show that 'resisters' possess IgM, class-switched IgG antibody responses and non-IFN-γ T cell responses to the Mtb-specific proteins ESAT6 and CFP10, immunologic evidence of exposure to Mtb. Compared to subjects with classic LTBI, 'resisters' display enhanced antibody avidity and distinct Mtb-specific IgG Fc profiles. These data reveal a distinctive adaptive immune profile among Mtb-exposed subjects, supporting an expanded definition of the host response to Mtb exposure, with implications for public health and the design of clinical trials.
|
520 |
|
|
|a Bill and Melinda Gates Foundation (Grant OPP1109001)
|
520 |
|
|
|a Bill and Melinda Gates Foundation (Grant OPP1151840)
|
520 |
|
|
|a Bill and Melinda Gates Foundation (Grant OPP1156795)
|
546 |
|
|
|a en
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Nature Medicine
|